ScreenerHero
SRTSartorius Aktiengesellschaft
XETRA · DE · Healthcare · Medical Instruments & Supplies · sartorius.com
196.20EUR-1.90%Mkt Cap: 14.73B $P/E: 69.08

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometr…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Société anonyme
$81.53BUSDP/E 30.5
BOX
Becton, Dickinson and Company
$49.98BUSDP/E 34.1
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech S.A.
$20.46BUSDP/E 64.5
SRT3
Sartorius Aktiengesellschaft
$18.52BUSDP/E 86.9
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1

Key Statistics

Company
Market Cap14.73B $
Enterprise Value20.38B $
Revenue (TTM)3.89B $
Gross Profit1.78B $
Net Income (TTM)168.37M $
Revenue/Share55.70 USD
Last Price196.20 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14.3K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE0007165631
Valuation
P/E (Trailing)69.08
P/E (Forward)30.25
PEG0.75
EV/EBITDA19.97
EV/Revenue5.23
P/S3.77
P/B4.98
EPS (TTM)2.84
EPS (Forward)6.46
52W Range
154.2078% of range208.00
52W High208.00 EUR
52W Low154.20 EUR
Profitability
Gross Margin46.26%
Oper. Margin18.00%
EBITDA Margin26.20%
Profit Margin4.38%
ROE5.72%
ROA1.59%
Growth
Revenue Growth3.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF909.78M $
CapEx (TTM)480.33M $
FCF Margin9.07%
FCF Yield2.40%
Net Debt4.09B $
Net Debt/EBITDA4.01
Balance Sheet
Debt/Equity1.58
Current Ratio1.14
Quick Ratio0.48
Book Value/Sh39.20 EUR
Cash/Share4.219 EUR
Dividends
Fwd Div Rate0.7300 EUR
Trail. Div Rate0.7400 EUR
Div. Yield0.37%
5Y Avg Yield0.38%
Payout Ratio25.80%
Ex-Div DateMar 27, 2026
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2016
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)249.53 EUR
Upside (mean)+27.2%
Target Range68.75 EUR – 445.00 EUR
€68.75+27.2% to mean€445.00
# Analysts9
Ownership
Shares Out.34.24M
Float27.45M
Insiders87.07%
Institutions1.47%
Technical
SMA 50185.47 (+5.8%)
SMA 200184.41 (+6.4%)
Beta1.46
S&P 52W Chg18.16%
Avg Vol (30d)3.09K
Avg Vol (10d)2.16K
Technical Indicators
RSI (14)63.4
MACD2.0585
MACD Signal0.9288
MACD Hist.+1.1297
BB Upper199.46 EUR
BB Middle183.96 EUR
BB Lower168.46 EUR
BB Width16.85%
ATR (14)7.276 EUR
Vol Ratio (20d)1.94x